CEVA INC

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

CEVA$24.84-8.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. FINANCIAL STATEMENTS

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

U.S. dollars in thousands, except share and per share data

	September 30, 2026	December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents	$29,608	$40,586
Short-term bank deposits	5,119	2,095
Marketable securities	185,953	179,302
Trade receivables (net of allowance for credit losses of $0 and $288 at September 30, 2026 and December 31, 2025, respectively)	46,489	49,355
Prepaid expenses and other current assets	14,235	13,498
Total current assets	281,404	284,836
Long-term assets:
Severance pay fund	6,901	7,530
Deferred tax assets, net	303	257
Property and equipment, net	9,161	7,054
Operating lease right-of-use assets	16,727	17,486
Goodwill	58,308	58,308
Intangible assets, net	532	1,044
Investments in marketable equity securities	127	55
Other long-term assets	17,148	11,686
Total long-term assets	109,207	103,420
Total assets	$390,611	$388,256
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Trade payables	$1,243	$2,418
Deferred revenues	3,444	3,496
Accrued expenses and other payables	4,714	5,181
Accrued payroll and related benefits	13,664	15,845
Operating lease liabilities	2,797	1,743
Total current liabilities	25,862	28,683
Long-term liabilities:
Accrued severance pay	7,113	7,690
Operating lease liabilities	14,040	14,388
Other accrued liabilities	1,224	1,037
Total long-term liabilities	22,377	23,115
Stockholders’ equity:
Preferred Stock, $0.001 par value; 5,000,000 shares authorized; none issued and outstanding	—	—
Common Stock, $0.001 par value; 45,000,000 shares authorized; 28,526,321 and 27,583,325 shares issued at September 30, 2026 and December 31, 2025, respectively; 28,526,321 and 27,510,739 shares outstanding at September 30, 2026 and December 31, 2025, respectively	29	28
Additional paid-in capital	354,941	337,966
Treasury stock at cost (0 and 72,586 shares of common stock at September 30, 2026 and December 31, 2025, respectively)	—	(1,591)
Accumulated other comprehensive income (loss)	(2,904)	79
Accumulated deficit	(9,694)	(24)
Total stockholders’ equity	342,372	336,458
Total liabilities and stockholders’ equity	$390,611	$388,256

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF LOSS (UNAUDITED)

U.S. dollars in thousands, except per share data

Nine months ended · Three months ended
	September 30,		September 30,
	2026	2025	2026	2025
Revenues:
Licensing and related revenues	$52,379	$46,092	$16,338	$16,028
Royalties	32,741	32,215	12,725	12,356
Total revenues	85,120	78,307	29,063	28,384
Cost of revenues	11,627	10,428	4,252	3,392
Gross profit	73,493	67,879	24,811	24,992
Operating expenses:
Research and development, net	57,297	55,899	18,128	19,532
Sales and marketing	10,980	9,783	3,935	3,012
General and administrative	15,557	12,697	6,154	4,383
Amortization of intangible assets	336	448	110	149
Total operating expenses	84,170	78,827	28,327	27,076
Operating loss	(10,677)	(10,948)	(3,516)	(2,084)
Financial income, net	5,156	5,466	2,301	1,245
Remeasurement of marketable equity securities	72	(261)	(16)	1
Loss before taxes on income	(5,449)	(5,743)	(1,231)	(838)
Income tax expense	4,221	3,797	1,070	1,671
Net loss	$(9,670)	$(9,540)	$(2,301)	$(2,509)
Basic and diluted net loss per share	$(0.35)	$(0.40)	$(0.08)	$(0.10)
Weighted-average shares used to compute net loss per share (in thousands):
Basic and diluted	28,001	23,869	28,323	23,942

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED)

U.S. dollars in thousands

Nine months ended · Three months ended
	September 30,		September 30,
	2026	2025	2026	2025
Net loss	$(9,670)	$(9,540)	$(2,301)	$(2,509)
Other comprehensive income (loss) before tax:
Available-for-sale securities:
Changes in unrealized gains (losses)	(2,987)	1,497	(2,036)	483
Reclassification adjustments included in net loss	(2)	(16)	(2)	—
Net change	(2,989)	1,481	(2,038)	483
Cash flow hedges:
Changes in unrealized gains (losses)	539	1,212	(203)	66
Reclassification adjustments included in net loss	(606)	(1,009)	144	(648)
Net change	(67)	203	(59)	(582)
Other comprehensive income (loss) before tax	(3,056)	1,684	(2,097)	(99)
Income tax expense (benefit) related to components of other comprehensive income (loss)	(73)	153	(52)	44
Other comprehensive income (loss), net of taxes	(2,983)	1,531	(2,045)	(143)
Comprehensive loss	$(12,653)	$(8,009)	$(4,346)	$(2,652)

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’** EQUITY (UNAUDITED)**

U.S. dollars in thousands, except share data

Common stock
Nine months ended September 30, 2026 · Number of shares outstanding · Amount · Additional paid-in capital · Treasury stock · Accumulated other comprehensive income (loss) · Accumulated deficit · Total stockholders’ equity
Balance as of January 1, 2026	27,510,739	$28		$337,966	$(1,591)	$79	$(24)	$336,458
Net loss	—	—		—	—	—	(9,670)	(9,670)
Other comprehensive loss, net	—	—		—	—	(2,983)	—	(2,983)
Equity-based compensation	—	—		15,535	—	—	—	15,535
Issuance of common stock upon exercise of stock-based awards	942,996	1		3,031	—	—	—	3,032
Issuance of treasury stock upon exercise of stock-based awards	72,586	—	(*)	(1,591)	1,591	—	—	—
Balance as of September 30, 2026	28,526,321	$29		$354,941	$—	$(2,904)	$(9,694)	$342,372

Common stock
Three months ended September 30, 2026	Number of shares outstanding	Amount	Additional paid-in capital	Treasury stock	Accumulated other comprehensive loss	Accumulated deficit	Total stockholders’ equity
Balance as of July 1, 2026	28,137,917	$28	$348,469	$—	$(859)	$(7,393)	$340,245
Net loss	—	—	—	—	—	(2,301)	(2,301)
Other comprehensive loss, net	—	—	—	—	(2,045)	—	(2,045)
Equity-based compensation	—	—	4,992	—	—	—	4,992
Issuance of common stock upon exercise of stock-based awards	388,404	1	1,480	—	—	—	1,481
Balance as of September 30, 2026	28,526,321	$29	$354,941	$—	$(2,904)	$(9,694)	$342,372

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’** EQUITY (UNAUDITED)**

U.S. dollars in thousands, except share data

Common stock
Nine months ended September 30, 2025 · Number of shares outstanding · Amount · Additional paid-in capital · Treasury stock · Accumulated other comprehensive income (loss) · Retained earnings · Total stockholders’ equity
Balance as of January 1, 2025	23,626,865	$24		$259,891	$(3,222)	$(1,330)	$11,193	$266,556
Net loss	—	—		—	—	—	(9,540)	(9,540)
Other comprehensive income, net	—	—		—	—	1,531	—	1,531
Equity-based compensation	—	—		14,098	—	—	—	14,098
Purchase of treasury stock	(340,295)	—	(*)	—	(7,150)	—	—	(7,150)
Issuance of common stock upon exercise of stock-based awards	377,070	—	(*)	1,358	—	—	—	1,358
Issuance of treasury stock upon exercise of stock-based awards	353,213	—	(*)	(5,403)	7,819	—	(550)	1,866
Balance as of September 30, 2025	24,016,853	$24		$269,944	$(2,553)	$201	$1,103	$268,719

Common stock
Three months ended September 30, 2025 · Number of shares outstanding · Amount · Additional paid-in capital · Treasury stock · Accumulated other comprehensive income (loss) · Retained earnings · Total stockholders’ equity
Balance as of July 1, 2025	23,847,325	$24		$267,743	$(5,874)	$344	$3,655	$265,892
Net loss	—	—		—	—	—	(2,509)	(2,509)
Other comprehensive loss, net	—	—		—	—	(143)	—	(143)
Equity-based compensation	—	—		4,873	—	—	—	4,873
Purchase of treasury stock	(40,295)	—	(*)	—	(988)	—	—	(988)
Issuance of treasury stock upon exercise of stock-based awards	209,823	—	(*)	(2,672)	4,309	—	(43)	1,594
Balance as of September 30, 2025	24,016,853	$24		$269,944	$(2,553)	$201	$1,103	$268,719

(*)	Amount less than $1.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

U.S. dollars in thousands

	Nine months ended September 30,
	2026	2025
Cash flows from operating activities:
Net loss	$(9,670)	$(9,540)
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	1,979	2,495
Amortization of intangible assets	512	625
Equity-based compensation	15,535	14,098
Realized gain on sale of available-for-sale marketable securities	(2)	(16)
Accretion of discount on available-for-sale marketable securities	(220)	(635)
Unrealized foreign exchange (gain) loss	1,323	(1,123)
Remeasurement of marketable equity securities	(72)	261
Changes in operating assets and liabilities:
Trade receivables, net	2,655	(12,224)
Prepaid expenses and other assets	(6,728)	(477)
Operating lease right-of-use assets	759	1,849
Accrued interest on bank deposits	(35)	8
Deferred tax, net	27	(99)
Trade payables	(1,171)	442
Deferred revenues	(52)	(547)
Accrued expenses and other payables	(336)	(920)
Accrued payroll and related benefits	(2,354)	(4,220)
Operating lease liability	258	(2,121)
Accrued severance pay, net	44	64
Net cash provided by (used in) operating activities	2,452	(12,080)
Cash flows from investing activities:
Purchase of property and equipment	(4,027)	(1,428)
Proceeds from the sale of Intrinsix	—	3,470
Investment in bank deposits	(5,868)	(2,705)
Proceeds from bank deposits	2,863	2,000
Investment in available-for-sale marketable securities	(118,960)	(49,843)
Proceeds from maturity of available-for-sale marketable securities	99,216	59,197
Proceeds from sale of available-for-sale marketable securities	10,326	3,914
Net cash provided by (used in) investing activities	(16,450)	14,605
Cash flows from financing activities:
Purchase of treasury stock	—	(7,150)
Proceeds from exercise of stock-based awards	3,032	3,224
Net cash provided by (used in) financing activities	3,032	(3,926)
Effect of exchange rate changes on cash and cash equivalents	(12)	173
Decrease in cash and cash equivalents	(10,978)	(1,228)
Cash and cash equivalents at the beginning of the period	40,586	18,498
Cash and cash equivalents at the end of the period	$29,608	$17,270
Supplemental information of cash flow activities:
Cash paid during the period for:
Income and withholding taxes	$5,417	$1,900
Non-cash transactions:
Property and equipment purchases incurred but unpaid at period end	$54	$198
Right-of-use assets obtained in the exchange for operating lease liabilities	$446	$94

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.